116 related articles for article (PubMed ID: 65801)
1. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
Korsan-Bengtsen K; Johsen M; Pehrsson NG
Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
[TBL] [Abstract][Full Text] [Related]
2. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
3. Regional quality control of coagulation assay procedures (normotest, simplastin-a and thrombotest).
Kahan J
Thromb Diath Haemorrh; 1974 Sep; 32(1):79-89. PubMed ID: 4454048
[TBL] [Abstract][Full Text] [Related]
4. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
Mischke R; Deniz A; Nolte I
Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
Latallo ZS; Thomson JM; Poller L
Br J Haematol; 1981 Feb; 47(2):307-18. PubMed ID: 7470395
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin determination by means of a chromogenic peptide substrate.
Axelsson G; Korsan-Bengtsen K; Waldenström J
Thromb Haemost; 1976 Dec; 36(3):517-24. PubMed ID: 65799
[TBL] [Abstract][Full Text] [Related]
7. The application of the Reaction Rate Analyser LKB 8600 as an automatic coagulometer.
Andersen I; Thorsen S
Scand J Clin Lab Invest; 1977 Feb; 37(1):7-13. PubMed ID: 616030
[TBL] [Abstract][Full Text] [Related]
8. [Clinical use of a test for determination of coagulation factors II, X and VII].
Cascino A; Cangiano C; Attili AF
Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. I. Correlations between the variables of clotting and fibrinolysis.
Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
Thromb Diath Haemorrh; 1972 Aug; 28(1):89-98. PubMed ID: 5074993
[No Abstract] [Full Text] [Related]
10. [Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study].
Barthels M; Bruhn HD; Duckert F; Meyer JG; Dati F; Fuhge P
J Clin Chem Clin Biochem; 1987 Apr; 25(4):267-80. PubMed ID: 3625130
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
12. [Capillary blood coagulation in the healthy premature newborn].
Alexandre P; Andre E; Streiff F; Vert P
Arch Fr Pediatr; 1975 May; 32(5):417-31. PubMed ID: 1181994
[TBL] [Abstract][Full Text] [Related]
13. [Activity of coagulation factors II, V, VII and X in healthy dogs--dependence on age, sex and breed].
Mischke R
Berl Munch Tierarztl Wochenschr; 1994 Sep; 107(9):289-94. PubMed ID: 7980377
[TBL] [Abstract][Full Text] [Related]
14. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
Korsan-Bengtsen K
Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
[No Abstract] [Full Text] [Related]
15. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
Rogner G
Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
[No Abstract] [Full Text] [Related]
16. Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.
Loeliger EA; Meuwisse-Braun JB; Muis H; Buitendijk FJ; Veltkamp JJ; Hemker HC
Thromb Diath Haemorrh; 1970 Jun; 23(3):569-84. PubMed ID: 5432194
[No Abstract] [Full Text] [Related]
17. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X].
Pagliano FM; Cestari G; Slucca P
Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839
[TBL] [Abstract][Full Text] [Related]
19. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
20. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
Mischke R
Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
